Substituted 9-(1 or 3-monoacyloxy or 1,3-diacyloxy-2-propoxymethyl) purines as antiviral agent
AssigneeSyntex Corporation
InventorsJulien P. H. Verheyden, John C. Martin
Life of this patent
Estimating the term…
Loading patent…
AssigneeSyntex Corporation
InventorsJulien P. H. Verheyden, John C. Martin
Estimating the term…
Compounds useful as antiviral agents are defined by the following formula: ##STR1## and the pharmaceutically acceptable acid addition salts thereof wherein R.sup.1 is hydrogen or --C(O)R.sup.7 wherein R.sup.7 is hydrogen, alkyl of one to nineteen carbon atoms, hydroxyalkyl of one to eight carbon atoms, alkoxyalkyl of two to nine carbon atoms, alkenyl of two to nineteen carbon atoms, phenyl, 1-adamantyl or 2-carboxyethyl and the pharmaceutically acceptable alkali metal salts thereof; R.sup.2 is --C(O)R.sup.7 wherein R.sup.7 is as defined above; R.sup.3 is hydrogen, halo, thio, lower alkylthio of one to six carbon atoms, azido, NR.sup.9 R.sup.10 wherein R.sup.9 and R.sup.10 are independently hydrogen or lower alkyl of one to six carbon atoms or --NHC(O)R.sup.8 wherein R.sup.8 is hydrogen, alkyl of one to nineteen carbon atoms or 1-adamantyl; and (a) R.sup.6 is hydrogen, halo, lower alkoxy of one to six carbon atoms, azido, thio, lower alkylthio of one to six carbon atoms, --NR.sup.9 R.sup.10 wherein R.sup.9 and R.sup.10 are as defined above or --NHC(O)R.sup.8 wherein R.sup.8 is as defined above and R.sup.4 together with R.sup.5 is a bond; or (b) R.sup.5 together with R.sup.6 is a keto group and R.sup.4 is hydrogen.
A compound of the formula ##STR6## of a pharmaceutically acceptable acid addition salt thereof wherein R.sup.1 is hydrogen or --C(O)R.sup.7 wherein R.sup.7 is hydrogen, alkyl of one to nineteen carbon atoms, hydroxyalkyl of one to eight carbon atoms, alkoxyalkyl of two to nine carbon atoms, alkenyl of two to nineteen carbon atoms, phenyl, or 2-carboxyethyl and the pharmaceutically acceptable alkali metal salts thereof;
A pharmaceutical composition which comprises a pharmaceutically acceptable carrier and a compound of the formula ##STR8## or a pharmaceutically acceptable salt thereof wherein R.sup.1 is hydrogen or --C(O)R.sup.7 wherein R.sup.7 is hydrogen, alkyl of one to nineteen carbon atoms, hydroxyalkyl of one to eight carbon atoms, alkoxyalkyl of two to nine carbon atoms, alkenyl of two to nineteen carbon atoms, phenyl, or 2-carboxyethyl and the pharmaceutically acceptable alkali metal salts thereof;
A method of treating viral infection in a warm blooded or a cold blooded animal having a viral infection which comprises administering an effective amount of a compound of the formula ##STR10## or a pharmaceutically acceptable salt thereof wherein R.sup.1 is hydrogen or --C(O)R.sup.7 wherein R.sup.7 is hydrogen, alkyl of one to nineteen carbon atoms, hydroxyalkyl of one to eight carbon atoms, alkoxyalkyl of two to nine carbon atoms, alkenyl of two to nineteen carbon atoms, phenyl, or 2-carboxyethyl and the pharmaceutically acceptable alkali metal salts thereof;
Dependencies are inferred from the claim text.